Endocrine effects of goserelin, a new depot luteinising hormone releasing hormone agonist.
作者信息
Thomas E J, Jenkins J, Lenton E A, Cooke I D
出版信息
Br Med J (Clin Res Ed). 1986 Nov 29;293(6559):1407-8. doi: 10.1136/bmj.293.6559.1407-a.
Abstract
摘要
相似文献
1
Endocrine effects of goserelin, a new depot luteinising hormone releasing hormone agonist.
Br Med J (Clin Res Ed). 1986 Nov 29;293(6559):1407-8. doi: 10.1136/bmj.293.6559.1407-a.
2
The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer.促黄体生成素释放激素激动剂（ICI 118630，诺雷德）在绝经前晚期乳腺癌中的应用。
Br J Cancer. 1986 May;53(5):629-36. doi: 10.1038/bjc.1986.106.
3
Biodegradable polymer luteinising hormone releasing hormone analogue for prostatic cancer: use of a new peptide delivery system.用于前列腺癌的可生物降解聚合物促黄体生成素释放激素类似物：一种新型肽递送系统的应用
Br Med J (Clin Res Ed). 1984 Dec 8;289(6458):1580-1. doi: 10.1136/bmj.289.6458.1580.
4
Luteinizing hormone-releasing hormone analog therapy of uterine fibroid: analysis of results obtained with buserelin administered intranasally and goserelin administered subcutaneously as a monthly depot.促黄体生成激素释放激素类似物治疗子宫肌瘤：对经鼻给予布舍瑞林和每月皮下注射戈舍瑞林作为长效注射剂所获结果的分析。
Eur J Obstet Gynecol Reprod Biol. 1990 Oct;37(1):63-9. doi: 10.1016/0028-2243(90)90096-j.
5
Endocrinologic and clinical evaluation following a single administration of a gonadotrophin-releasing hormone agonist (Zoladex), in a depot formulation, to premenopausal women.
Fertil Steril. 1988 Jan;49(1):163-5. doi: 10.1016/s0015-0282(16)59670-8.
6
Treatment of a patient with severe menstrual migraine using the depot LHRH analogue Zoladex.使用长效促性腺激素释放激素（LHRH）类似物诺雷德治疗重度月经性偏头痛患者。
Aust N Z J Obstet Gynaecol. 1991 May;31(2):164-5. doi: 10.1111/j.1479-828x.1991.tb01808.x.
7
Goserelin depot in the treatment of premenopausal advanced breast cancer.
Eur J Cancer. 1992;28A(4-5):810-4. doi: 10.1016/0959-8049(92)90120-q.
8
Endocrine effects of combination antioestrogen and LH-RH agonist therapy in premenopausal patients with advanced breast cancer.
Eur J Cancer Clin Oncol. 1989 Apr;25(4):651-4. doi: 10.1016/0277-5379(89)90200-9.
9
Estrogenic action of tamoxifen in women treated with luteinizing hormone-releasing hormone agonists (goserelin)--lack of shrinkage of uterine fibroids.他莫昔芬在接受促黄体生成素释放激素激动剂（戈舍瑞林）治疗的女性中的雌激素作用——子宫肌瘤无缩小
Fertil Steril. 1989 Dec;52(6):924-9. doi: 10.1016/s0015-0282(16)53153-7.
10
Treatment of pre-menopausal advanced breast cancer with goserelin--a long-acting luteinizing hormone releasing hormone agonist.
Anticancer Drugs. 1992 Feb;3(1):3-8. doi: 10.1097/00001813-199202000-00001.
引用本文的文献
1
Pharmacological sex hormone manipulation as a risk model for depression.药物性激素操控作为抑郁症的风险模型。
J Neurosci Res. 2020 Jul;98(7):1283-1292. doi: 10.1002/jnr.24632. Epub 2020 May 12.
2
Two different formulations with equivalent effect? Comparison of serum estradiol suppression with monthly goserelin and trimonthly leuprolide in breast cancer patients.两种等效作用的不同配方？每月戈舍瑞林和每三月亮丙瑞林在乳腺癌患者中抑制血清雌二醇的比较。
Med Oncol. 2013 Mar;30(1):354. doi: 10.1007/s12032-012-0354-1. Epub 2012 Dec 29.
3
Goserelin: a review of its use in the treatment of early breast cancer in premenopausal and perimenopausal women.戈舍瑞林：用于治疗绝经前和围绝经期妇女早期乳腺癌的综述
Drugs. 2005;65(18):2639-55. doi: 10.2165/00003495-200565180-00011.
4
Clinical pharmacokinetics of goserelin.戈舍瑞林的临床药代动力学
Clin Pharmacokinet. 2000 Jul;39(1):27-48. doi: 10.2165/00003088-200039010-00003.
5
Luteinizing hormone-releasing hormone analogues--the rationale for adjuvant use in premenopausal women with early breast cancer.促黄体生成激素释放激素类似物——绝经前早期乳腺癌女性辅助治疗的理论依据。
Br J Cancer. 1998 Sep;78 Suppl 4(Suppl 4):5-8. doi: 10.1038/bjc.1998.754.
6
Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in benign gynaecological disorders.戈舍瑞林。对其药效学和药代动力学特性以及在良性妇科疾病中的治疗应用的综述。
Drugs. 1996 Feb;51(2):319-46. doi: 10.2165/00003495-199651020-00009.
7
Successful treatment of infertility due to polycystic ovary disease using a combination of luteinising hormone releasing hormone agonist and low dosage menotrophin.使用促黄体生成素释放激素激动剂和低剂量尿促性素联合治疗多囊卵巢病所致不孕症取得成功。
Br Med J (Clin Res Ed). 1987 Jul 11;295(6590):96. doi: 10.1136/bmj.295.6590.96.
8
Acne and psoriasis.痤疮和银屑病。
Br Med J (Clin Res Ed). 1988 Feb 20;296(6621):546-8.
9
Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use in sex hormone-related conditions.戈舍瑞林。对其药效学和药代动力学特性以及在性激素相关病症中的临床应用的综述。
Drugs. 1991 Feb;41(2):254-88. doi: 10.2165/00003495-199141020-00008.
10
Shrinkage of uterine fibroids by preoperative LHRH analogue injection.术前注射促性腺激素释放激素类似物使子宫肌瘤缩小。
Ulster Med J. 1992 Apr;61(1):51-5.
本文引用的文献
1
Biodegradable sustained release formulation of the LH-RH analogue 'Zoladex' for the treatment of hormone-responsive tumours.
Prog Clin Biol Res. 1985;185A:143-53.
Zotero 插件